Peter F. Ambros

22.6k citations

221 papers · 13.7k indexed · 6 hit papers · h-index 55

Neurology top 0.05%
- Neuroblastoma Research and Treatments 110
- Neurofibromatosis and Schwannoma Cases 17
Cancer Research top 0.2%
- Cancer, Hypoxia, and Metabolism 41
Oncology top 1%
- Lung Cancer Research Studies 17
Molecular Biology top 0.5%
- Cancer therapeutics and mechanisms 31
Genetics top 1%
- Virus-based gene therapy research 19
Pulmonary and Respiratory Medicine
- Sarcoma Diagnosis and Treatment 23
Epidemiology
- Neuroendocrine Tumor Research Advances 21

Co-authors: Inge M. Ambros Susan L. Cohn Helmut Gadner Katherine K. Matthay Wendy B. London Andrew D.J. Pearson Olivier Delattre Sabine Strehl
Cited by: Neurology Cancer Research Oncology
Partner nations: Austria United States Germany

In The Last Decade

Peter F. Ambros

216 papers receiving 13.4k citations

Hit Papers

6 papers align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2015 Advances in Risk Classification and Treatment Strategies for Neuroblastoma
2008 The International Neuroblastoma Risk Group (INRG) Staging System: An INRG Task Force Report
2008 The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report
1998 Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer
1994 The Ewing Family of Tumors -- A Subgroup of Small-Round-Cell Tumors Defined by Specific Chimeric Transcripts
1991 MIC2 is a specific marker for ewing's sarcoma and peripheral primitive neuroectodermal tumors. Evidence for a common histogenesis of ewing's sarcoma and peripheral primitive neuroectodermal tumors from MIC2 expression and specific chromosome aberration

Peers

Countries citing papers authored by Peter F. Ambros

Since Specialization

Citations

This map shows the geographic impact of Peter F. Ambros's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter F. Ambros with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter F. Ambros more than expected).

Fields of papers citing papers by Peter F. Ambros

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter F. Ambros. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter F. Ambros. The network helps show where Peter F. Ambros may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Peter F. Ambros, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter F. Ambros Line = papers co-authored together Peter F. Ambros links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Impact of Disseminated Neuroblastoma Cells on the Identification of the Relapse-Seeding Clone Mojtaba Abbasi,Fikret Rifatbegovic,Clemens Brunner,Georg Mann,Andrea Ziegler,Ulrike Pötschger,Roman Crazzolara,Marek Ussowicz,Martin Benesch,Georg Ebetsberger‐Dachs,Godfrey Chi Fung Chan,Neil D. Jones,Ruth Ladenstein,Inge M. Ambros,Peter F. Ambros	2017	25
2	Comparative genetic study of intratumoral heterogenous MYCN amplified neuroblastoma versus aggressive genetic profile neuroblastic tumors Ana P. Berbegall,Eva Villamón,Marta Piqueras,Irene Tadeo,Anna Djos,Peter F. Ambros,Tommy Martinsson,I.M. Ambros,Adela Cañete,Victoria Castel,S. Navarro,Rosa Noguera	2015	21
3	Screening for adenoviruses in haematological neoplasia: High prevalence in mantle cell lymphoma Karin Kosulin,Margit Rauch,Peter F. Ambros,Ulrike Pötschger,Andreas Chott,Ulrich Jäger,Johannes Drach,Alexander Nader,Thomas Lion	2013	6
4	Prognostic Value of the Stage 4S Metastatic Pattern and Tumor Biology in Patients With Metastatic Neuroblastoma Diagnosed Between Birth and 18 Months of Age Denah R. Taggart,Wendy B. London,Mary Lou Schmidt,Steven G. DuBois,Tom Monclair,Akira Nakagawara,Bruno De Bernardi,Peter F. Ambros,Andrew D.J. Pearson,Susan L. Cohn,Katherine K. Matthay	2011	48
5	Clinical and Biologic Features Predictive of Survival After Relapse of Neuroblastoma: A Report From the International Neuroblastoma Risk Group Project Wendy B. London,Victoria Castel,Tom Monclair,Peter F. Ambros,Andrew D.J. Pearson,Susan L. Cohn,Frank Berthold,Akira Nakagawara,Ruth Ladenstein,Tomoko Iehara,Katherine K. Matthay	2011	229
6	Identification of the human homolog of the imprinted mouse Air non-coding RNA Iveta Yotova,Irena Vlatkovic,Florian M. Pauler,Katarzyna E. Warczok,Peter F. Ambros,Mitsuo Oshimura,Hans‐Christian Theussl,Manfred Gessler,Erwin F. Wagner,Denise P. Barlow	2008	39
7	Rapid determination of Epstein–Barr virus latent or lytic infection in single human cells using in situ hybridization Е Е Леенман,Renate Panzer‐Grümayer,Susanna Fischer,Heather A. Leitch,Douglas E. Horsman,Thomas Lion,Helmut Gadner,Peter F. Ambros,Valia S. Lestou	2004	15
8	Frequent Low Level Expression in Ewing Sarcoma Family Tumors and Widespread Absence of the Metastasis Suppressor KAI1/CD82 in Neuroblastoma Dave N.T. Aryee,Inge M. Ambros,Peter F. Ambros,Karin Muehlbacher,A. Luegmayr,Osamu Yoshie,Heinrich Kovar	2002	6
9	Neuroblastoma with focal MYCN amplification and bone marrow infiltration: A staging and treatment dilemma Reinhold Kerbl,Inge M. Ambros,Peter F. Ambros,Herwig Lackner,Hans Jürgen Dornbusch,Christian Urban	2002	16
10	Detection and relocation of rare events Simone Hennerbichler,Gábor Méhes,Rudolf Schmied,Reinhold Wintersteiger,Gottfried Dohr,Peter F. Ambros,Peter Sedlmayr	2002	5
11	Detecting disseminated solid tumor cells in hematopoietic samples: methodological aspects Méhes,Peter F. Ambros,Gadner	2001	6
12	Intratumoural heterogeneity of 1p deletions andMYCN amplification in neuroblastomas Peter F. Ambros,I.M. Ambros,Reinhold Kerbl,A. Luegmayr,S. Rumpler,Ruth Ladenstein,Gabriele Amann,Heinrich Kovar,Ernst Horcher,Bruno De Bernardi,Jean Michon,Helmut Gadner	2001	52
13	Molecular analysis of chromosome arm 17q gain in neuroblastoma Isabelle Janoueix‐Lerosey,Dominique Penther,Martine Thioux,Patricia de Cr�moux,Josette Derr�,Peter F. Ambros,Philippe Vielh,Jean B�nard,Alain Aurias,Olivier Delattre	2000	26
14	Duplication of a Genomic Region Containing the Cdc2L1-2 and MMP21-22 Genes on Human Chromosome 1p36.3 and their Linkage to D1Z2 Rajagopal Gururajan,Jill M. Lahti,José Grenet,John Easton,Irmhild Gruber,Peter F. Ambros,Vincent J. Kidd	1998	51
15	[5 years neuroblastoma screening in Austria: rate of participation, results and a comparison with other screening areas]. Reinhold Kerbl,Urban Ce,R. Ladenstein,C Schnellauf,Christian Sitzwohl,Herwig Lackner,H. Gleispach,Günter Fauler,Peter F. Ambros,IM Ambros,S. Rumpler,H. Gadner,Ekkehard Spuller,Gerald Höfler,Gabriele Amann,J Kytir,I Mutz	1996	3
16	Screening for neuroblastoma in late infancy by use of EIA (enzyme-linked immunoassay) method: 115 000 screened infants in Austria Reinhold Kerbl,Christian Urban,Peter F. Ambros,Herwig Lackner,Ruth Ladenstein,Ekkehard Spuller,I Mutz,I.M. Ambros,Gabriele Amann,Helmut Gadner,Louise Parker	1996	11
17	Variability of EWS chimaeric transcripts in Ewing tumours: a comparison of clinical and molecular data A. Zoubek,Christa Pfleiderer,M. Salzer‐Kuntschik,Gabriele Amann,Reinhard Windhager,F. M. Fink,Ewa Kościelniak,Olivier Delattre,Sabine Strehl,Peter F. Ambros,Helmut Gadner,Heinrich Kovar	1994	78
18	Homology-dependent gene silencing in transgenic plants: epistatic silencing loci contain multiple copies of methylated transgenes A. J. M. Matzke,Franz Neuhuber,Young‐Doo Park,Peter F. Ambros,Marjori Matzke	1994	182
19	Detection of numerical and structural chromosome abnormalities in pediatric germ cell tumors by means of interphase cytogenetics Cornelia Stock,Inge M. Ambros,Thomas Lion,Oskar A. Haas,A. Zoubek,Helmut Gadner,Peter F. Ambros	1994	58
20	Demonstration of specific heterochromatic segments in the orangutan (<i>Pongo pygmaeus</i>) by a distamycin/DAPI double staining technique Dieter Schweizer,Peter F. Ambros,Milly Andrle,A Rett,Wolfgang Fiedler	1979	16

About Peter F. Ambros

Peter F. Ambros is a scholar working on Neurology, Cancer Research and Molecular Biology, having authored 221 papers that have together received 13.7k indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (110 papers), Cancer, Hypoxia, and Metabolism (41 papers), Cancer therapeutics and mechanisms (31 papers), Sarcoma Diagnosis and Treatment (23 papers), Neuroendocrine Tumor Research Advances (21 papers), Virus-based gene therapy research (19 papers), Neurofibromatosis and Schwannoma Cases (17 papers) and Lung Cancer Research Studies (17 papers). The work is most often cited by research in Neurology (6.1k citations), Cancer Research (3.2k citations) and Oncology (2.6k citations). Peter F. Ambros has collaborated with scholars based in Austria, United States and Germany. Frequent co-authors include Inge M. Ambros, Susan L. Cohn, Helmut Gadner, Katherine K. Matthay, Wendy B. London, Andrew D.J. Pearson, Olivier Delattre, Sabine Strehl, Dieter Schweizer and Alain Aurias.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact